These novel findings provide valuable insights into the oncogenic properties of PTHrP in prostate cancer and underscore its potential as a promising therapeutic target, potentially offering new approaches to the diagnosis and treatment of prostate cancer. This evidence concerns the gene PTHLH and Familial prostate cancer.